SOCS-1 Promoter Methylation and Treatment Response in Chronic Hepatitis C Patients Receiving Pegylated-Interferon/Ribavirin

By Tseng Kuo-Chih   Chou Jian-Liang   Huang Hsien-Bin   Tseng Chih-Wei   Wu Shu-Fen   Chan Michael  

Journal of Clinical Immunology, Vol. 33, Iss. 6, 2013-08 ,pp. : 1110-1116

Springer Publishing Company

Access to resources Recommend Favorite

Suspected Simultaneous Bilateral Anterior Ischemic Optic Neuropathy in a Patient with Behçet's Disease

By Yamauchi Yasuyuki   Cruz Jose   Kaplan Henry   Goto Hiroshi   Sakai Jun-ichi   Usui Masahiko  

Ocular Immunology and Inflammation, Vol. 13, Iss. 4, 2005-08 ,pp. : 317-325

Informa Healthcare

Access to resources Recommend Favorite

Oligoclonal CD8⁺ T-Cell Expansion in Patients with Chronic Hepatitis C Is Associated with Liver Pathology and Poor Response to Interferon-α Therapy

By Manfras Burkhard J.   Weidenbach Hans   Beckh Karl-Heinz   Kern Peter   Möller Peter   Adler Guido   Mertens Thomas   Boehm Bernhard O.  

Journal of Clinical Immunology, Vol. 24, Iss. 3, 2004-05 ,pp. : 258-271

Springer Publishing Company

Access to resources Recommend Favorite

Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin

By Campos-de-Magalhães Marilza   Eduardo Brandão-Mello Carlos   Lúcia Elias Pires Maria   Cecília da Fonseca Salgado Maria   Barcelo de Brito Selma   José de Almeida Adilson  

Hematology, Vol. 16, Iss. 2, 2011-03 ,pp. : 80-85

Maney Publishing

Access to resources Recommend Favorite

Daily interferon Alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection

By Beckebaum S.   Cicinnati V.R.   Karliova M.   Dirsch O.   Erim Y.   Frilling A.   Malago M.   Broelsch C.E.   Treichel U.   Gerken G.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2080-2081

Elsevier

Access to resources Recommend Favorite